Zydus Cadila begins supply of Covid-19 vaccine to Centre
New Delhi, February 2: Zydus Cadila on Wednesday said it had started the supplies of its Covid-19 vaccine ZyCoV-D to the Centre.
In a statement, the drug firm said the supply had been initiated as per the order placed by the Centre. Plans are also to make Zydus Cadila's Covid-19 vaccine ZyCoV-D available in the private market, the statement added.
Also read | Comedian Sunil Grover undergoes heart surgery, recuperating
ZyCoV-D is a three-dose vaccine administered intradermally. “The vaccine will be priced at Rs 265 per dose and the applicator being offered at Rs 93 per dose, excluding GST,” Zydus Cadila said.
The Ahmedabad-based drugmaker has also entered into a definitive agreement with Shilpa Medicare Ltd, a contract manufacturing organisation, to produce mutually agreeable doses of ZyCoV-D.
ZyCoV-D is a Plasmid DNA vaccine that produces the spike protein of the SARS-CoV-2 virus and elicits an immune response mediated by the cellular and humoral arms of the human immune system, which play a vital role in protection from disease as well as viral clearance.
Also read | Covid-19 'less severe' in fully vaccinated people
-PTC News with agency inputs
